Tokyo robotics company BionicM announced a ¥710 million first closing of its Series B, approximately $4.5 million using the company’s conversion, on November 10.
The amount includes earlier J-KISS convertible equity investments. It should therefore not be treated as entirely new cash received on the announcement date.
Manufacturing and US expansion
Participants include B Dash Ventures and Mitsubishi UFJ Capital, alongside overseas investors and angels. BionicM plans to strengthen production and US sales ahead of its planned 2027 launch of ASISTA, a powered prosthetic knee.
The device is designed to actively assist knee bending and extension. Product benefits described in the release are company claims, not an independent assessment of clinical effectiveness.
Separating the round from cumulative financing
BionicM reports ¥2.58 billion in total funding, including both equity and government grants. That cumulative figure is separate from the ¥710 million Series B first close.
Founder and CEO Xiaojun Sun developed the business from robotics research at the University of Tokyo. A valuation was not disclosed.
Sources
BionicM — official announcement via PR Newswire. Image: company-supplied announcement graphic.